In cisplatin-resistant CRC cells, curcumin disrupts glutamine metabolic homeostasis by inducing miR-137, which inhibits glutaminase (GLS) activity, thus restoring chemosensitivity to cisplatin [133]. Here, GLS is linked to colorectal carcinoma.